The Phillies medical staff does not prescribe the anti-inflammatory medication Toradol for its players, GM Ruben Amaro Jr. said on Monday. “We don’t believe in it,” Amaro said. "We don't think it's necessary." On Monday, ran a story detailing the Boston Red Sox’ use of the controversial drug. The drug, which is said to cause side effects such as gastrointestinal bleeding, is legal and not prohibited by Major League Baseball. In the story, Phils closer Jonathan Papelbon said he was treated with the drug during his time with the Red Sox from 2007 to 2011. When he joined the Phillies before the 2012 season, he was told that he wouldn’t be able to use it anymore. Papelbon didn’t suffer from not using Toradol. He appeared in a career-high 70 games and was 38 for 42 in save chances. “My understanding is that [Toradol] is something that’s pretty prevalent around the league, but something we do not recommend,” Amaro said. “Short-term, long-term effects, we just don’t feel it’s a viable rehab choice for our players. We’ve stayed away from it. [Papelbon] was fine last year and very effective, so that’s a good thing. “This is a non-issue for us. It doesn’t affect the Philadelphia Phillies.” Papelbon told the that the Phillies use “safer anti-inflammatories.” Citing policy, Amaro would not comment on the treatment Phillies players receive.